These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36992197)

  • 1. Anaphylactic Reactions to COVID-19 Vaccines: An Updated Assessment Based on Pharmacovigilance Data.
    Boufidou F; Hatziantoniou S; Theodoridou K; Maltezou HC; Vasileiou K; Anastassopoulou C; Medić S; Tsakris A
    Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse events of acute nephrotoxicity reported to EudraVigilance and VAERS after COVID-19 vaccination.
    Anastassopoulou C; Boufidou F; Hatziantoniou S; Vasileiou K; Spanakis N; Tsakris A
    Vaccine; 2023 Nov; 41(48):7176-7182. PubMed ID: 37891048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative assessment of myocarditis and pericarditis reporting rates related to mRNA COVID-19 vaccines in Europe and the United States.
    Hatziantoniou S; Anastassopoulou C; Lazaros G; Vasileiou K; Tsioufis C; Tsakris A
    Expert Rev Vaccines; 2022 Nov; 21(11):1691-1696. PubMed ID: 35815358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anaphylactic and nonanaphylactic reactions to SARS-CoV-2 vaccines: a systematic review and meta-analysis.
    Alhumaid S; Al Mutair A; Al Alawi Z; Rabaan AA; Tirupathi R; Alomari MA; Alshakhes AS; Alshawi AM; Ahmed GY; Almusabeh HM; Alghareeb TT; Alghuwainem AA; Alsulaiman ZA; Alabdulmuhsin MA; AlBuwaidi EA; Dukhi AKB; Mufti HN; Al-Qahtani M; Dhama K; Al-Tawfiq JA; Al-Omari A
    Allergy Asthma Clin Immunol; 2021 Oct; 17(1):109. PubMed ID: 34656181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency and Associations of Adverse Reactions of COVID-19 Vaccines Reported to Pharmacovigilance Systems in the European Union and the United States.
    Montano D
    Front Public Health; 2021; 9():756633. PubMed ID: 35186864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anaphylaxis is a rare reaction in COVID-19 vaccination.
    Bellomo RG; Gallenga CE; Caraffa A; Tetè G; Ronconi G; Conti P
    J Biol Regul Homeost Agents; 2021; 35(3):839-842. PubMed ID: 34105336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allergic reactions to coronavirus disease 2019 vaccines and addressing vaccine hesitancy: Northwell Health experience.
    Kaplan B; Farzan S; Coscia G; Rosenthal DW; McInerney A; Jongco AM; Ponda P; Bonagura VR
    Ann Allergy Asthma Immunol; 2022 Feb; 128(2):161-168.e1. PubMed ID: 34699968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of anaphylaxis behind authorized COVID-19 vaccines: a meta-analysis.
    Sobczak M; Pawliczak R
    Clin Mol Allergy; 2022 Jan; 20(1):1. PubMed ID: 35039051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between pre-existing allergies and anaphylactic reactions post mRNA COVID-19 vaccine administration.
    Desai AP; Desai AP; Loomis GJ
    Vaccine; 2021 Jul; 39(32):4407-4409. PubMed ID: 34215453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 vaccination including 198 patients with history of severe anaphylactic reaction - own observations.
    Wentrys Ł; Stopyra L
    Przegl Epidemiol; 2021; 75(3):315-325. PubMed ID: 35170287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anaphylaxis rates associated with COVID-19 vaccines are comparable to those of other vaccines.
    Maltezou HC; Anastassopoulou C; Hatziantoniou S; Poland GA; Tsakris A
    Vaccine; 2022 Jan; 40(2):183-186. PubMed ID: 34863620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Allergic and Anaphylactic Reactions to mRNA COVID-19 Vaccines With Confirmatory Testing in a US Regional Health System.
    Warren CM; Snow TT; Lee AS; Shah MM; Heider A; Blomkalns A; Betts B; Buzzanco AS; Gonzalez J; Chinthrajah RS; Do E; Chang I; Dunham D; Lee G; O'Hara R; Park H; Shamji MH; Schilling L; Sindher SB; Sisodiya D; Smith E; Tsai M; Galli SJ; Akdis C; Nadeau KC
    JAMA Netw Open; 2021 Sep; 4(9):e2125524. PubMed ID: 34533570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 mRNA Vaccines Are Generally Safe in the Short Term: A Vaccine Vigilance Real-World Study Says.
    Chen G; Li X; Sun M; Zhou Y; Yin M; Zhao B; Li X
    Front Immunol; 2021; 12():669010. PubMed ID: 34093567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allergic Reactions to COVID-19 Vaccines: Risk Factors, Frequency, Mechanisms and Management.
    Luxi N; Giovanazzi A; Arcolaci A; Bonadonna P; Crivellaro MA; Cutroneo PM; Ferrajolo C; Furci F; Guidolin L; Moretti U; Olivieri E; Petrelli G; Zanoni G; Senna G; Trifirò G
    BioDrugs; 2022 Jul; 36(4):443-458. PubMed ID: 35696066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allergic reactions to Japanese encephalitis vaccine.
    Plesner AM
    Immunol Allergy Clin North Am; 2003 Nov; 23(4):665-97. PubMed ID: 14753386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allergy to COVID-19 vaccines: A current update.
    Cabanillas B; Novak N
    Allergol Int; 2021 Jul; 70(3):313-318. PubMed ID: 33962863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reporting rates of yellow fever vaccine 17D or 17DD-associated serious adverse events in pharmacovigilance data bases: systematic review.
    Thomas RE; Lorenzetti DL; Spragins W; Jackson D; Williamson T
    Curr Drug Saf; 2011 Jul; 6(3):145-54. PubMed ID: 22122389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Allergy and Hypersensitivity Reactions to COVID-19 Vaccines According to the EudraVigilance Database.
    Romantowski J; Nazar W; Bojahr K; Popiołek I; Niedoszytko M
    Life (Basel); 2024 May; 14(6):. PubMed ID: 38929698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with previous immediate hypersensitivity reactions to polyethylene glycol can safely receive the BNT162b2 mRNA COVID-19 vaccine.
    Hurst M; Jordan A; Capstick J; Brewerton M; Cockroft R; Ingram J
    Intern Med J; 2022 Oct; 52(10):1818-1820. PubMed ID: 36000384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active and passive surveillance of yellow fever vaccine 17D or 17DD-associated serious adverse events: systematic review.
    Thomas RE; Lorenzetti DL; Spragins W; Jackson D; Williamson T
    Vaccine; 2011 Jun; 29(28):4544-55. PubMed ID: 21549787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.